glp-1/gip dual agonist mechanism of action Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to and triple agonists Not all GLP-1–based therapies Options:3 Bottles gifts for holidays

glp-1/gip dual agonist mechanism of action Incretin-based therapies in MASLD/MASH: from GLP-1 receptor agonists to and triple agonists Not all GLP-1–based therapies Options:3 Bottles gifts for holidays

Not all GLP-1–based therapies work the same way. Semaglutide targets the GLP -1 receptor, while tirzepatide targets both GLP-1 and GIP receptors. Retatrutide is being studied as a triple-receptor agonist targeting GLP-1, GIP

Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: a new opportunity

gifts for holidays

Options:3 Bottles

Saxenda, Victoza, and Trulicity still matter It is easy for older medications to get overlooked in a conversation dominated by semaglutide and tirzepatide, but Saxenda, Victoza, and Trulicity still have an important place in care